The Applications of Single-Cell RNA Sequencing in Atherosclerotic Disease

Publication date

2022-02-08

Authors

Slenders, Lotte
Tessels, Daniëlle E
van der Laan, Sander W.ORCID 0000-0001-6888-1404
Pasterkamp, GerardISNI 0000000397161080
Mokry, MichalORCID 0000-0002-5298-4852ISNI 0000000387648231

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Atherosclerosis still is the primary cause of death worldwide. Our characterization of the atherosclerotic lesion is mainly rooted in definitions based on pathological descriptions. We often speak in absolutes regarding plaque phenotypes: vulnerable vs. stable plaques or plaque rupture vs. plaque erosion. By focusing on these concepts, we may have oversimplified the atherosclerotic disease and its mechanisms. The widely used definitions of pathology-based plaque phenotypes can be fine-tuned with observations made with various -omics techniques. Recent advancements in single-cell transcriptomics provide the opportunity to characterize the cellular composition of the atherosclerotic plaque. This additional layer of information facilitates the in-depth characterization of the atherosclerotic plaque. In this review, we discuss the impact that single-cell transcriptomics may exert on our current understanding of atherosclerosis.

Keywords

-omics, atherosclerosis, scRNA-sequencing, single-cell, transcriptomics

Citation

Slenders, L, Tessels, D E, van der Laan, S W, Pasterkamp, G & Mokry, M 2022, 'The Applications of Single-Cell RNA Sequencing in Atherosclerotic Disease', Frontiers in cardiovascular medicine, vol. 9, 826103, pp. 1-12. https://doi.org/10.3389/fcvm.2022.826103